世界の化学療法誘発性貧血市場規模・現状・予測2021-2027

【英語タイトル】Global Chemotherapy Induced Anemia Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1272)・商品コード:QY21APR1272
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、化学療法誘発性貧血の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(軽度貧血、中等度貧血、重度貧血、致死的貧血)、用途別市場規模(病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセンター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・化学療法誘発性貧血の市場動向
・企業の競争状況、市場シェア
・化学療法誘発性貧血の種類別市場規模(軽度貧血、中等度貧血、重度貧血、致死的貧血)
・化学療法誘発性貧血の用途別市場規模(病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセンター)
・化学療法誘発性貧血の北米市場規模2016-2027(アメリカ、カナダ)
・化学療法誘発性貧血の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・化学療法誘発性貧血のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・化学療法誘発性貧血の中南米市場規模2016-2027(メキシコ、ブラジル)
・化学療法誘発性貧血の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Dr. Reddy’s Laboratories、Pfizer、Panacea Biotec、3SBio、SBI Pharmaceuticals、Tolero Pharmaceuticals、Vifor Pharma、Therapure Biopharma)
・結論
【レポートの概要】

Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy.
The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients.

Market Analysis and Insights: Global Chemotherapy Induced Anemia Market
The global Chemotherapy Induced Anemia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemotherapy Induced Anemia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemotherapy Induced Anemia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemotherapy Induced Anemia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemotherapy Induced Anemia market.

Global Chemotherapy Induced Anemia Scope and Market Size
Chemotherapy Induced Anemia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Anemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mild Anemia
Moderate Anemia
Severe Anemia
Life-Threatening Anemia

Segment by Application
Hospitals
Ambulatory Surgical Centers
Multispecialty Clinics
Cancer Research Centers
Cancer Rehabilitation Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dr. Reddy’s Laboratories
Pfizer
Panacea Biotec
3SBio
SBI Pharmaceuticals
Tolero Pharmaceuticals
Vifor Pharma
Therapure Biopharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotherapy Induced Anemia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mild Anemia
1.2.3 Moderate Anemia
1.2.4 Severe Anemia
1.2.5 Life-Threatening Anemia
1.3 Market by Application
1.3.1 Global Chemotherapy Induced Anemia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Multispecialty Clinics
1.3.5 Cancer Research Centers
1.3.6 Cancer Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chemotherapy Induced Anemia Market Perspective (2016-2027)
2.2 Chemotherapy Induced Anemia Growth Trends by Regions
2.2.1 Chemotherapy Induced Anemia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemotherapy Induced Anemia Historic Market Share by Regions (2016-2021)
2.2.3 Chemotherapy Induced Anemia Forecasted Market Size by Regions (2022-2027)
2.3 Chemotherapy Induced Anemia Industry Dynamic
2.3.1 Chemotherapy Induced Anemia Market Trends
2.3.2 Chemotherapy Induced Anemia Market Drivers
2.3.3 Chemotherapy Induced Anemia Market Challenges
2.3.4 Chemotherapy Induced Anemia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy Induced Anemia Players by Revenue
3.1.1 Global Top Chemotherapy Induced Anemia Players by Revenue (2016-2021)
3.1.2 Global Chemotherapy Induced Anemia Revenue Market Share by Players (2016-2021)
3.2 Global Chemotherapy Induced Anemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemotherapy Induced Anemia Revenue
3.4 Global Chemotherapy Induced Anemia Market Concentration Ratio
3.4.1 Global Chemotherapy Induced Anemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy Induced Anemia Revenue in 2020
3.5 Chemotherapy Induced Anemia Key Players Head office and Area Served
3.6 Key Players Chemotherapy Induced Anemia Product Solution and Service
3.7 Date of Enter into Chemotherapy Induced Anemia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy Induced Anemia Breakdown Data by Type
4.1 Global Chemotherapy Induced Anemia Historic Market Size by Type (2016-2021)
4.2 Global Chemotherapy Induced Anemia Forecasted Market Size by Type (2022-2027)

5 Chemotherapy Induced Anemia Breakdown Data by Application
5.1 Global Chemotherapy Induced Anemia Historic Market Size by Application (2016-2021)
5.2 Global Chemotherapy Induced Anemia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chemotherapy Induced Anemia Market Size (2016-2027)
6.2 North America Chemotherapy Induced Anemia Market Size by Type
6.2.1 North America Chemotherapy Induced Anemia Market Size by Type (2016-2021)
6.2.2 North America Chemotherapy Induced Anemia Market Size by Type (2022-2027)
6.2.3 North America Chemotherapy Induced Anemia Market Size by Type (2016-2027)
6.3 North America Chemotherapy Induced Anemia Market Size by Application
6.3.1 North America Chemotherapy Induced Anemia Market Size by Application (2016-2021)
6.3.2 North America Chemotherapy Induced Anemia Market Size by Application (2022-2027)
6.3.3 North America Chemotherapy Induced Anemia Market Size by Application (2016-2027)
6.4 North America Chemotherapy Induced Anemia Market Size by Country
6.4.1 North America Chemotherapy Induced Anemia Market Size by Country (2016-2021)
6.4.2 North America Chemotherapy Induced Anemia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chemotherapy Induced Anemia Market Size (2016-2027)
7.2 Europe Chemotherapy Induced Anemia Market Size by Type
7.2.1 Europe Chemotherapy Induced Anemia Market Size by Type (2016-2021)
7.2.2 Europe Chemotherapy Induced Anemia Market Size by Type (2022-2027)
7.2.3 Europe Chemotherapy Induced Anemia Market Size by Type (2016-2027)
7.3 Europe Chemotherapy Induced Anemia Market Size by Application
7.3.1 Europe Chemotherapy Induced Anemia Market Size by Application (2016-2021)
7.3.2 Europe Chemotherapy Induced Anemia Market Size by Application (2022-2027)
7.3.3 Europe Chemotherapy Induced Anemia Market Size by Application (2016-2027)
7.4 Europe Chemotherapy Induced Anemia Market Size by Country
7.4.1 Europe Chemotherapy Induced Anemia Market Size by Country (2016-2021)
7.4.2 Europe Chemotherapy Induced Anemia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chemotherapy Induced Anemia Market Size (2016-2027)
8.2 Asia-Pacific Chemotherapy Induced Anemia Market Size by Type
8.2.1 Asia-Pacific Chemotherapy Induced Anemia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemotherapy Induced Anemia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemotherapy Induced Anemia Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemotherapy Induced Anemia Market Size by Application
8.3.1 Asia-Pacific Chemotherapy Induced Anemia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemotherapy Induced Anemia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemotherapy Induced Anemia Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemotherapy Induced Anemia Market Size by Region
8.4.1 Asia-Pacific Chemotherapy Induced Anemia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemotherapy Induced Anemia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chemotherapy Induced Anemia Market Size (2016-2027)
9.2 Latin America Chemotherapy Induced Anemia Market Size by Type
9.2.1 Latin America Chemotherapy Induced Anemia Market Size by Type (2016-2021)
9.2.2 Latin America Chemotherapy Induced Anemia Market Size by Type (2022-2027)
9.2.3 Latin America Chemotherapy Induced Anemia Market Size by Type (2016-2027)
9.3 Latin America Chemotherapy Induced Anemia Market Size by Application
9.3.1 Latin America Chemotherapy Induced Anemia Market Size by Application (2016-2021)
9.3.2 Latin America Chemotherapy Induced Anemia Market Size by Application (2022-2027)
9.3.3 Latin America Chemotherapy Induced Anemia Market Size by Application (2016-2027)
9.4 Latin America Chemotherapy Induced Anemia Market Size by Country
9.4.1 Latin America Chemotherapy Induced Anemia Market Size by Country (2016-2021)
9.4.2 Latin America Chemotherapy Induced Anemia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chemotherapy Induced Anemia Market Size (2016-2027)
10.2 Middle East & Africa Chemotherapy Induced Anemia Market Size by Type
10.2.1 Middle East & Africa Chemotherapy Induced Anemia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemotherapy Induced Anemia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemotherapy Induced Anemia Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemotherapy Induced Anemia Market Size by Application
10.3.1 Middle East & Africa Chemotherapy Induced Anemia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemotherapy Induced Anemia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemotherapy Induced Anemia Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemotherapy Induced Anemia Market Size by Country
10.4.1 Middle East & Africa Chemotherapy Induced Anemia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemotherapy Induced Anemia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dr. Reddy’s Laboratories
11.1.1 Dr. Reddy’s Laboratories Company Details
11.1.2 Dr. Reddy’s Laboratories Business Overview
11.1.3 Dr. Reddy’s Laboratories Chemotherapy Induced Anemia Introduction
11.1.4 Dr. Reddy’s Laboratories Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.1.5 Dr. Reddy’s Laboratories Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Chemotherapy Induced Anemia Introduction
11.2.4 Pfizer Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Panacea Biotec
11.3.1 Panacea Biotec Company Details
11.3.2 Panacea Biotec Business Overview
11.3.3 Panacea Biotec Chemotherapy Induced Anemia Introduction
11.3.4 Panacea Biotec Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.3.5 Panacea Biotec Recent Development
11.4 3SBio
11.4.1 3SBio Company Details
11.4.2 3SBio Business Overview
11.4.3 3SBio Chemotherapy Induced Anemia Introduction
11.4.4 3SBio Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.4.5 3SBio Recent Development
11.5 SBI Pharmaceuticals
11.5.1 SBI Pharmaceuticals Company Details
11.5.2 SBI Pharmaceuticals Business Overview
11.5.3 SBI Pharmaceuticals Chemotherapy Induced Anemia Introduction
11.5.4 SBI Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.5.5 SBI Pharmaceuticals Recent Development
11.6 Tolero Pharmaceuticals
11.6.1 Tolero Pharmaceuticals Company Details
11.6.2 Tolero Pharmaceuticals Business Overview
11.6.3 Tolero Pharmaceuticals Chemotherapy Induced Anemia Introduction
11.6.4 Tolero Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.6.5 Tolero Pharmaceuticals Recent Development
11.7 Vifor Pharma
11.7.1 Vifor Pharma Company Details
11.7.2 Vifor Pharma Business Overview
11.7.3 Vifor Pharma Chemotherapy Induced Anemia Introduction
11.7.4 Vifor Pharma Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.7.5 Vifor Pharma Recent Development
11.8 Therapure Biopharma
11.8.1 Therapure Biopharma Company Details
11.8.2 Therapure Biopharma Business Overview
11.8.3 Therapure Biopharma Chemotherapy Induced Anemia Introduction
11.8.4 Therapure Biopharma Revenue in Chemotherapy Induced Anemia Business (2016-2021)
11.8.5 Therapure Biopharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chemotherapy Induced Anemia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mild Anemia
Table 3. Key Players of Moderate Anemia
Table 4. Key Players of Severe Anemia
Table 5. Key Players of Life-Threatening Anemia
Table 6. Global Chemotherapy Induced Anemia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chemotherapy Induced Anemia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chemotherapy Induced Anemia Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chemotherapy Induced Anemia Market Share by Regions (2016-2021)
Table 10. Global Chemotherapy Induced Anemia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chemotherapy Induced Anemia Market Share by Regions (2022-2027)
Table 12. Chemotherapy Induced Anemia Market Trends
Table 13. Chemotherapy Induced Anemia Market Drivers
Table 14. Chemotherapy Induced Anemia Market Challenges
Table 15. Chemotherapy Induced Anemia Market Restraints
Table 16. Global Chemotherapy Induced Anemia Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chemotherapy Induced Anemia Market Share by Players (2016-2021)
Table 18. Global Top Chemotherapy Induced Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Anemia as of 2020)
Table 19. Ranking of Global Top Chemotherapy Induced Anemia Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chemotherapy Induced Anemia Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chemotherapy Induced Anemia Product Solution and Service
Table 23. Date of Enter into Chemotherapy Induced Anemia Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chemotherapy Induced Anemia Revenue Market Share by Type (2016-2021)
Table 27. Global Chemotherapy Induced Anemia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chemotherapy Induced Anemia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chemotherapy Induced Anemia Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chemotherapy Induced Anemia Revenue Market Share by Application (2016-2021)
Table 31. Global Chemotherapy Induced Anemia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chemotherapy Induced Anemia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chemotherapy Induced Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chemotherapy Induced Anemia Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chemotherapy Induced Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chemotherapy Induced Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chemotherapy Induced Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chemotherapy Induced Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chemotherapy Induced Anemia Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chemotherapy Induced Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chemotherapy Induced Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chemotherapy Induced Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chemotherapy Induced Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chemotherapy Induced Anemia Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chemotherapy Induced Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chemotherapy Induced Anemia Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chemotherapy Induced Anemia Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chemotherapy Induced Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chemotherapy Induced Anemia Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chemotherapy Induced Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chemotherapy Induced Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chemotherapy Induced Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chemotherapy Induced Anemia Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chemotherapy Induced Anemia Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chemotherapy Induced Anemia Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chemotherapy Induced Anemia Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chemotherapy Induced Anemia Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chemotherapy Induced Anemia Market Size by Country (2022-2027) & (US$ Million)
Table 63. Dr. Reddy’s Laboratories Company Details
Table 64. Dr. Reddy’s Laboratories Business Overview
Table 65. Dr. Reddy’s Laboratories Chemotherapy Induced Anemia Product
Table 66. Dr. Reddy’s Laboratories Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 67. Dr. Reddy’s Laboratories Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Chemotherapy Induced Anemia Product
Table 71. Pfizer Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Panacea Biotec Company Details
Table 74. Panacea Biotec Business Overview
Table 75. Panacea Biotec Chemotherapy Induced Anemia Product
Table 76. Panacea Biotec Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 77. Panacea Biotec Recent Development
Table 78. 3SBio Company Details
Table 79. 3SBio Business Overview
Table 80. 3SBio Chemotherapy Induced Anemia Product
Table 81. 3SBio Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 82. 3SBio Recent Development
Table 83. SBI Pharmaceuticals Company Details
Table 84. SBI Pharmaceuticals Business Overview
Table 85. SBI Pharmaceuticals Chemotherapy Induced Anemia Product
Table 86. SBI Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 87. SBI Pharmaceuticals Recent Development
Table 88. Tolero Pharmaceuticals Company Details
Table 89. Tolero Pharmaceuticals Business Overview
Table 90. Tolero Pharmaceuticals Chemotherapy Induced Anemia Product
Table 91. Tolero Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 92. Tolero Pharmaceuticals Recent Development
Table 93. Vifor Pharma Company Details
Table 94. Vifor Pharma Business Overview
Table 95. Vifor Pharma Chemotherapy Induced Anemia Product
Table 96. Vifor Pharma Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 97. Vifor Pharma Recent Development
Table 98. Therapure Biopharma Company Details
Table 99. Therapure Biopharma Business Overview
Table 100. Therapure Biopharma Revenue in Chemotherapy Induced Anemia Business (2016-2021) & (US$ Million)
Table 101. Therapure Biopharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy Induced Anemia Market Share by Type: 2020 VS 2027
Figure 2. Mild Anemia Features
Figure 3. Moderate Anemia Features
Figure 4. Severe Anemia Features
Figure 5. Life-Threatening Anemia Features
Figure 6. Global Chemotherapy Induced Anemia Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Multispecialty Clinics Case Studies
Figure 10. Cancer Research Centers Case Studies
Figure 11. Cancer Rehabilitation Centers Case Studies
Figure 12. Chemotherapy Induced Anemia Report Years Considered
Figure 13. Global Chemotherapy Induced Anemia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Chemotherapy Induced Anemia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Chemotherapy Induced Anemia Market Share by Regions: 2020 VS 2027
Figure 16. Global Chemotherapy Induced Anemia Market Share by Regions (2022-2027)
Figure 17. Global Chemotherapy Induced Anemia Market Share by Players in 2020
Figure 18. Global Top Chemotherapy Induced Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Anemia as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Chemotherapy Induced Anemia Revenue in 2020
Figure 20. Global Chemotherapy Induced Anemia Revenue Market Share by Type (2016-2021)
Figure 21. Global Chemotherapy Induced Anemia Revenue Market Share by Type (2022-2027)
Figure 22. North America Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Chemotherapy Induced Anemia Market Share by Type (2016-2027)
Figure 24. North America Chemotherapy Induced Anemia Market Share by Application (2016-2027)
Figure 25. North America Chemotherapy Induced Anemia Market Share by Country (2016-2027)
Figure 26. United States Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Chemotherapy Induced Anemia Market Share by Type (2016-2027)
Figure 30. Europe Chemotherapy Induced Anemia Market Share by Application (2016-2027)
Figure 31. Europe Chemotherapy Induced Anemia Market Share by Country (2016-2027)
Figure 32. Germany Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Chemotherapy Induced Anemia Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Chemotherapy Induced Anemia Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Chemotherapy Induced Anemia Market Share by Region (2016-2027)
Figure 42. China Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Chemotherapy Induced Anemia Market Share by Type (2016-2027)
Figure 50. Latin America Chemotherapy Induced Anemia Market Share by Application (2016-2027)
Figure 51. Latin America Chemotherapy Induced Anemia Market Share by Country (2016-2027)
Figure 52. Mexico Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Chemotherapy Induced Anemia Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Chemotherapy Induced Anemia Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Chemotherapy Induced Anemia Market Share by Country (2016-2027)
Figure 58. Turkey Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Chemotherapy Induced Anemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Dr. Reddy’s Laboratories Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 63. Panacea Biotec Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 64. 3SBio Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 65. SBI Pharmaceuticals Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 66. Tolero Pharmaceuticals Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 67. Vifor Pharma Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 68. Therapure Biopharma Revenue Growth Rate in Chemotherapy Induced Anemia Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【掲載企業】

Dr. Reddy’s Laboratories、Pfizer、Panacea Biotec、3SBio、SBI Pharmaceuticals、Tolero Pharmaceuticals、Vifor Pharma、Therapure Biopharma

★調査レポート[世界の化学療法誘発性貧血市場規模・現状・予測2021-2027] (コード:QY21APR1272)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の化学療法誘発性貧血市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆